Ventana to acquire Biotechnology Tools:
This article was originally published in Clinica
Executive Summary
Ventana Medical Systems is to buy Biotechnology Tools - which operates as RMC - for around $5 million in cash. Ventana says RMC's tissue processor and line of rotary microtomes complements its own range of immunohistochemistry and slide stainers. The deal, which should be completed by early October, is expected to add to Ventana's earnings by 1999. Both companies are based in Tucson, Arizona.
You may also be interested in...
Boehringer Ingelheim Overtakes Bayer As Germany’s Biggest Pharma Company
The privately-owned company is searching for a successor to Jardiance, while the outcome of US Inflation Reduction Act talks on price cuts to the blockbuster will be revealed in September.
Synthekine Joins Quest To Tame IL-2 In Cancer Therapies
First clinical data from Synthekine’s IL-2 candidate and that ofrivalsMedicennawere presented at the AACR, suggesting there’s life in the modality yet.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.